Daratumumab treatment shows promise for high-risk smoldering multiple myeloma in phase 3 trial

A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM).

PE Firm Thoma Bravo Makes Strategic Investment in Bluesight & Medacist Acquisition

What You Should Know: – Today Thoma Bravo, a private equity software investment firm, announced a strategic growth investment in Bluesight, the Medication Intelligence™ Company.

July 17, 2023

In Los Angeles, occupational therapists tapped to help homeless stay housed

Carla Brown waits on an air mattress, eager for her occupational therapist to arrive at her apartment next to the Hollywood Freeway, mere blocks from

January 24, 2024

Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Merger 06-March-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

March 7, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.